A method and system for analyzing characteristics of heterogeneous genetic data
By processing the patient's gene and transcriptomic data, it is determined whether the genetic disease is caused by gene mutations or abnormal gene expression, which solves the problem that the causes of the genetic disease cannot be analyzed in the prior art, improves the treatment efficiency and provides genetic probability data.
Patent Information
- Application Number
- CN202410445495.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-15
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-04-15
AI Technical Summary
The prior art cannot analyze and deal with the causes of the genetic disease patients suffer from, and cannot accurately determine the type of genetic disease patients suffer from, resulting in low treatment efficiency.
The data acquisition module obtains the patient's gene data and transcriptome data, process the determination values of gene mutations and gene expression abnormalities, combine preset thresholds and proportional coefficients, determine whether the genetic disease the patient suffers from is caused by gene mutations or gene expression abnormalities, and determine Types of genetic diseases.
Accurate analysis and type determination of the causes of the genetic disease patients suffer from is achieved, treatment efficiency is improved, and genetic probability data is provided for patients and offspring.
Smart Images

Figure CN118230814B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of biomedical engineering, and in particular to a method and system for analyzing characteristics of heterogeneous genetic data. Background Art
[0002] Heterogeneous multimodal imaging genetics methods combine data from different sources and natures. By combining multimodal data, this method can more accurately identify the characteristics of the disease, provide more information dimensions, and help distinguish different stages or types of the disease.
[0003] A Chinese patent application with publication number CN 115690556 B discloses an image recognition method and system based on multimodal imaging features, including: inputting a pre-acquired multimodal training image set into a pre-built convolutional neural network basic model to train a multimodal image abnormality recognition model; based on the multimodal image abnormality recognition model, identifying the multimodal images to be detected, and outputting abnormal area data in each modality image; aligning the multimodal images of the same detection part within the three-dimensional framework model of the corresponding part, and marking the abnormal area in each modality image; and fusing the associated abnormal areas together to form an abnormal block.
[0004] In the prior art, only the correlation analysis is performed on the abnormal areas in multiple modal images, and the abnormal areas with strong correlation are merged together to form abnormal blocks. The abnormal block information in the multimodal images is displayed in a three-dimensional model to improve the intuitive display effect of the abnormal areas and display more data information. However, the cause of the genetic disease suffered by the patient is not analyzed, and the type of genetic disease suffered by the patient is not obtained based on the cause of the genetic disease suffered by the patient. For this reason, the present invention provides a method and system for analyzing the characteristics of heterogeneous multimodal imaging genetics data. Summary of the invention
[0005] In order to make up for the deficiencies of the prior art, at least one technical problem raised in the background technology is solved.
[0006] The technical solution adopted by the present invention to solve the technical problem is: a method and system for analyzing the characteristics of heterogeneous genetic data, and the steps of the analysis method are as follows:
[0007] Step 1, obtaining data of patients with genetic diseases through a data acquisition module, wherein the genetic data includes the total number of genes detected in the patient, the number of genetic mutations, and the frequency of genetic mutations;
[0008] Step 2: Process the collected gene data to obtain a gene mutation determination value to determine whether the genetic disease suffered by the patient is caused by a gene mutation;
[0009] If the gene mutation determination value is greater than or equal to the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is caused by gene mutation;
[0010] If the gene mutation determination value is less than the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is not caused by gene mutation;
[0011] In step 2, the collected genetic data is processed as follows:
[0012] A1, sum up and count the number of gene mutations of the patients to obtain the total number of gene mutations;
[0013] A2, based on the three sets of data of single nucleotide variation frequency, insertion frequency and deletion frequency of the patient, the representative value of the single nucleotide variation frequency, the representative value of the insertion frequency and the representative value of the deletion frequency of the patient are processed to obtain the representative value of the gene variation frequency;
[0014] A3, processing the total number of detected patient genes, the total number of gene mutations, and the representative value of gene mutation frequency to obtain a gene mutation determination value;
[0015] In A2, the process of processing the patient's single nucleotide variation frequency representative value, insertion frequency representative value, and deletion frequency representative value is as follows:
[0016] A201, obtain the frequency of single nucleotide variations in the patient's gene sequence;
[0017] A202, obtain the insertion frequency within the patient's gene sequence;
[0018] A203, obtain the deletion frequency in the patient's gene sequence;
[0019] A204, by formula: Obtain the gene variation frequency representative value E, Pi represents the single nucleotide variation frequency representative value, Bi represents the insertion frequency representative value, Ti represents the deletion frequency representative value, and θ represents the preset proportionality coefficient;
[0020] In A3, the total number of genes, the total number of gene mutations and the representative value of gene mutation frequency obtained by the test are processed by a formula for ratio processing. The formula is: The gene mutation judgment value is obtained, Q represents the total number of patient genes detected, N represents the total number of gene mutations, and E represents the representative value of gene mutation frequency;
[0021] Step 3, obtaining the transcriptome data of the patient's genes, processing the patient's transcriptome data, obtaining a gene expression abnormality judgment value, and determining whether the patient's genetic disease is caused by abnormal gene expression;
[0022] In step 3, the specific process of processing the transcription data of the patient's gene is as follows:
[0023] B1, establish a two-dimensional coordinate system, overlap the transcriptome data of the patient's genes and the transcriptome data of the normal person's genes on the two-dimensional coordinate system, and obtain an overlapping statistical graph;
[0024] B2, processing and analyzing the trend line of the transcriptome data change of the patient's gene and the trend line of the transcriptome data change of the normal person's gene on the overlapping statistical graph, obtaining the deviation dispersion degree value of the transcriptome data of the patient's gene and the transcriptome data of the normal person's gene, and using the deviation dispersion degree value as the judgment value of abnormal gene expression;
[0025] In B2, the specific process of processing and analysis is as follows:
[0026] B201, obtaining the peak or trough value point of the transcriptome data change trend line of the patient's gene in the two-dimensional coordinate system;
[0027] B202, obtaining the peak or trough value point of the transcriptome data change trend line of normal human genes in the two-dimensional coordinate system;
[0028] B203, based on the peak or trough value points of the transcriptome data change trend line of the patient's gene and the peak or trough value points of the transcriptome data change trend line of the normal person's gene, processing to obtain the deviation value of the peak or trough value point, summing the deviation values to obtain the variance value, and using the variance value as the deviation dispersion value;
[0029] If the gene expression abnormality judgment value is greater than or equal to the preset gene expression abnormality judgment threshold, it is determined that the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene have a large degree of dispersion, and the genetic disease suffered by the patient is caused by abnormal gene expression;
[0030] If the abnormal gene expression judgment value is less than the preset abnormal gene expression judgment threshold, it is determined that the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene have a small degree of dispersion, and the genetic disease suffered by the patient is not caused by abnormal gene expression.
[0031] As a further solution of the present invention: Step 4, the gene mutation determination value and the gene expression abnormality determination value are processed to obtain a representative value of the genetic disease type, and the type of genetic disease suffered by the patient is determined.
[0032] As a further solution of the present invention: In step 4, the processing process of the gene mutation judgment value and the gene expression abnormality judgment value is as follows:
[0033] C1, by the formula: The representative value W of the genetic disease type is obtained, D represents the gene mutation judgment value, P represents the gene expression abnormality judgment value, and α and β represent the preset proportional coefficients;
[0034] C2, compare the genetic disease type determination value W with the preset genetic disease type determination threshold to obtain the genetic disease type.
[0035] The data acquisition module is used to obtain data of patients with genetic diseases, and the genetic data includes the total number of patient genes detected, the number of gene mutations, the frequency of gene mutations and the transcriptome data of the patient's genes;
[0036] The data processing module is used to process the number of gene mutations, the frequency of gene mutations and the transcriptome data of the patient's genes respectively to obtain the gene mutation judgment value and the gene expression abnormality judgment value;
[0037] If the gene mutation determination value is greater than or equal to the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is caused by gene mutation;
[0038] If the gene mutation determination value is less than the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is not caused by gene mutation;
[0039] If the gene expression abnormality judgment value is greater than or equal to the preset gene expression abnormality judgment threshold, it is determined that the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene have a large degree of dispersion, and the genetic disease suffered by the patient is caused by abnormal gene expression;
[0040] If the gene expression abnormality judgment value is less than the preset gene expression abnormality judgment threshold, it is determined that the divergence between the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene is small, and the genetic disease suffered by the patient is not caused by abnormal gene expression;
[0041] The data analysis module is used to analyze and determine the gene mutation judgment value and the gene expression abnormality judgment value to obtain the cause and type of the patient's genetic disease.
[0042] The beneficial effects of the present invention are as follows:
[0043] 1. A heterogeneous genetic data feature analysis method and system described in the present invention obtains data of patients with genetic diseases through a data acquisition module, the genetic data includes the total number of patient genes detected, the number of gene mutations and the frequency of gene mutations, the collected genetic data is processed to obtain a gene mutation determination value, and it is determined whether the genetic disease suffered by the patient is caused by gene mutation, the transcriptome data of the patient's genes is obtained, the patient's transcriptome data is processed to obtain a gene expression abnormality determination value, and it is determined whether the genetic disease suffered by the patient is caused by abnormal gene expression, the gene mutation determination value and the gene expression abnormality determination value are processed to obtain a representative value of the genetic disease type, and the type of genetic disease suffered by the patient is determined, thereby providing data for the inheritance probability of the patient's offspring genetic diseases, and further improving the efficiency of the treatment of genetic diseases for the patient and the patient's offspring.
[0044] 2. The method and system for analyzing the characteristics of heterogeneous genetic data described in the present invention obtains a total value of the number of gene mutations by summing up the number of gene mutations in patients, processes the representative value of the single nucleotide mutation frequency, the representative value of the insertion frequency and the representative value of the deletion frequency based on the three groups of data of the patient's single nucleotide mutation frequency, the insertion frequency and the deletion frequency to obtain a representative value of the gene mutation frequency, processes the total number of patient genes detected, the total number of gene mutations and the representative value of the gene mutation frequency to obtain a gene mutation judgment value, processes the transcription data of the patient's genes to obtain a deviation discrete degree value of the transcriptome data of the patient's genes and the transcriptome data of the normal person's genes, uses the deviation discrete degree value as a judgment value for abnormal gene expression, determines the cause of the patient's genetic disease, and thereby analyzes and obtains the specific cause of the patient's genetic disease. BRIEF DESCRIPTION OF THE DRAWINGS
[0045] The present invention will be further described below in conjunction with the accompanying drawings.
[0046] Figure 1 It is a flow chart for analyzing the characteristics of heterogeneous genetic data to determine the type of genetic disease a patient suffers from;
[0047] Figure 2 It is a flow chart of a heterogeneous genetic data feature analysis method to analyze whether a patient's genetic disease is caused by a gene mutation;
[0048] Figure 3 It is a flow chart of a heterogeneous genetic data feature analysis method to analyze whether a patient's genetic disease is caused by abnormal gene expression;
[0049] Figure 4 It is a module diagram of a heterogeneous genetics data feature analysis system. DETAILED DESCRIPTION
[0050] In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the present invention is further explained below in conjunction with specific implementation methods.
[0051] Embodiment 1
[0052] like Figure 1 - Figure 4 As shown, a heterogeneous genetic data feature analysis method according to an embodiment of the present invention includes the following analysis method steps:
[0053] Step 1, obtaining data of patients with genetic diseases through a data acquisition module, wherein the genetic data includes the total number of genes detected in the patient, the number of genetic mutations, and the frequency of genetic mutations;
[0054] Step 2: Process the collected gene data to obtain a gene mutation determination value to determine whether the genetic disease suffered by the patient is caused by a gene mutation;
[0055] A1, sum up and count the number of gene mutations of the patients to obtain the total number of gene mutations;
[0056] A2, based on the three sets of data of single nucleotide variation frequency, insertion frequency and deletion frequency of the patient, the representative value of the single nucleotide variation frequency, the representative value of the insertion frequency and the representative value of the deletion frequency of the patient are processed to obtain the representative value of the gene variation frequency;
[0057] A201, obtain the frequency of single nucleotide variations in the patient's gene sequence;
[0058] A202, obtain the insertion frequency within the patient's gene sequence;
[0059] A203, obtain the deletion frequency in the patient's gene sequence;
[0060] A204, by formula: Obtain the gene variation frequency representative value E, Pi represents the single nucleotide variation frequency representative value, Bi represents the insertion frequency representative value, Ti represents the deletion frequency representative value, and θ represents the preset proportionality coefficient;
[0061] A3, processing the total number of detected patient genes, the total number of gene mutations, and the representative value of gene mutation frequency to obtain a gene mutation determination value;
[0062] In A3, the total number of genes, the total number of gene mutations and the representative value of gene mutation frequency obtained by the test are processed by a formula for ratio processing. The formula is: The gene mutation judgment value D is obtained, Q represents the total number of patient genes detected, N represents the total number of gene mutations, and E represents the representative value of gene mutation frequency;
[0063] The gene mutation judgment value is compared with the preset gene mutation judgment threshold, and the comparison process is as follows:
[0064] If the gene mutation determination value is greater than or equal to the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is caused by gene mutation;
[0065] If the gene mutation determination value is less than the preset gene mutation determination threshold, it is determined that the patient's genetic disease is not caused by gene mutation:
[0066] Step 3, obtaining the transcriptome data of the patient's genes, processing the patient's transcriptome data, obtaining a gene expression abnormality judgment value, and determining whether the patient's genetic disease is caused by abnormal gene expression;
[0067] B1, establish a two-dimensional coordinate system, overlap the transcriptome data of the patient's genes and the transcriptome data of the normal person's genes on the two-dimensional coordinate system, and obtain an overlapping statistical graph;
[0068] B2, processing and analyzing the trend line of the transcriptome data change of the patient's gene and the trend line of the transcriptome data change of the normal person's gene on the overlapping statistical graph, obtaining the deviation dispersion degree value of the transcriptome data of the patient's gene and the transcriptome data of the normal person's gene, and using the deviation dispersion degree value as the judgment value of abnormal gene expression;
[0069] B201, obtaining the peak or trough value point of the transcriptome data change trend line of the patient's gene in the two-dimensional coordinate system;
[0070] B202, obtaining the peak or trough value point of the transcriptome data change trend line of normal human genes in the two-dimensional coordinate system;
[0071] B203, based on the peak or trough value points of the transcriptome data change trend line of the patient's gene and the peak or trough value points of the transcriptome data change trend line of the normal person's gene, processing to obtain the deviation value of the peak or trough value point, summing the deviation values to obtain the variance value, and using the variance value as the deviation dispersion value;
[0072] B3, comparing the abnormal gene expression judgment value with the preset abnormal gene expression judgment threshold, the comparison process is as follows:
[0073] If the gene expression abnormality judgment value is greater than or equal to the preset gene expression abnormality judgment threshold, it is determined that the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene have a large degree of dispersion, and the genetic disease suffered by the patient is caused by abnormal gene expression;
[0074] If the gene expression abnormality judgment value is less than the preset gene expression abnormality judgment threshold, it is determined that the divergence between the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene is small, and the genetic disease suffered by the patient is not caused by abnormal gene expression;
[0075] Embodiment 2
[0076] Step 4: Process the gene mutation determination value and the gene expression abnormality determination value to obtain a representative value of the genetic disease type, and determine the type of genetic disease that the patient suffers from based on the genetic disease type determination value;
[0077] C1, by the formula: The representative value W of the genetic disease type is obtained, D represents the gene mutation judgment value, P represents the gene expression abnormality judgment value, and α and β represent the preset proportional coefficients;
[0078] C2, compare the genetic disease type determination value W with the preset genetic disease type determination threshold, the specific comparison process is as follows:
[0079] If the genetic disease type determination value W is greater than or equal to the preset genetic disease type determination threshold, then the genetic disease type suffered by the patient is determined to be a dominant genetic disease;
[0080] If the genetic disease type determination value W is less than the preset genetic disease type determination threshold, it is determined that the genetic disease type suffered by the patient is a recessive genetic disease.
[0081] Embodiment 3
[0082] A heterogeneous genetics data feature analysis system, comprising: a data acquisition module, a data processing module and a data analysis module;
[0083] The data acquisition module is used to obtain data of patients with genetic diseases, and the genetic data includes the total number of patient genes detected, the number of gene mutations, the frequency of gene mutations and the transcriptome data of the patient's genes;
[0084] The data processing module is used to process the number of gene mutations, the frequency of gene mutations and the transcriptome data of the patient's genes respectively to obtain the gene mutation judgment value and the gene expression abnormality judgment value;
[0085] The data analysis module is used to analyze and determine the gene mutation judgment value and the gene expression abnormality judgment value to obtain the cause and type of the patient's genetic disease.
[0086] The above shows and describes the basic principles, main features and advantages of the present invention. It should be understood by those skilled in the art that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention. The scope of protection of the present invention is defined by the attached claims and their equivalents.
Claims
1. A method for analyzing features of heterogeneous genetic data. Features: The analysis method steps are as follows: Step 1, obtaining data of patients with genetic diseases through a data acquisition module, wherein the genetic data includes the total number of genes detected in the patient, the number of genetic mutations, and the frequency of genetic mutations; Step 2: Process the collected gene data to obtain a gene mutation determination value to determine whether the genetic disease suffered by the patient is caused by a gene mutation; If the gene mutation determination value is greater than or equal to the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is caused by gene mutation; If the gene mutation determination value is less than the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is not caused by gene mutation; In step 2, the collected genetic data is processed as follows: A1, sum up and count the number of gene mutations of the patients to obtain the total number of gene mutations; A2, based on the three sets of data of single nucleotide variation frequency, insertion frequency and deletion frequency of the patient, the representative value of the single nucleotide variation frequency, the representative value of the insertion frequency and the representative value of the deletion frequency of the patient are processed to obtain the representative value of the gene variation frequency; A3, processing the total number of detected patient genes, the total number of gene mutations, and the representative value of gene mutation frequency to obtain a gene mutation determination value; In A2, the process of processing the patient's single nucleotide variation frequency representative value, insertion frequency representative value, and deletion frequency representative value is as follows: A201, obtain the frequency of single nucleotide variations in the patient's gene sequence; A202, obtain the insertion frequency within the patient's gene sequence; A203, obtain the deletion frequency in the patient's gene sequence; A204, by formula: Obtain the gene variation frequency representative value E, Pi represents the single nucleotide variation frequency representative value, Bi represents the insertion frequency representative value, Ti represents the deletion frequency representative value, and θ represents the preset proportionality coefficient; In A3, the total number of genes, the total number of gene mutations and the representative value of gene mutation frequency obtained by the test are processed by a formula for ratio processing. The formula is: The gene mutation judgment value is obtained, Q represents the total number of patient genes detected, N represents the total number of gene mutations, and E represents the representative value of gene mutation frequency; Step 3, obtaining the transcriptome data of the patient's genes, processing the patient's transcriptome data, obtaining a gene expression abnormality judgment value, and determining whether the patient's genetic disease is caused by abnormal gene expression; In step 3, the specific process of processing the transcription data of the patient's gene is as follows: B1, establish a two-dimensional coordinate system, overlap the transcriptome data of the patient's genes and the transcriptome data of the normal person's genes on the two-dimensional coordinate system, and obtain an overlapping statistical graph; B2, processing and analyzing the trend line of the transcriptome data change of the patient's gene and the trend line of the transcriptome data change of the normal person's gene on the overlapping statistical graph, obtaining the deviation dispersion degree value of the transcriptome data of the patient's gene and the transcriptome data of the normal person's gene, and using the deviation dispersion degree value as the judgment value of abnormal gene expression; In B2, the specific process of processing and analysis is as follows: B201, obtaining the peak or trough value point of the transcriptome data change trend line of the patient's gene in the two-dimensional coordinate system; B202, obtaining the peak or trough value point of the transcriptome data change trend line of normal human genes in the two-dimensional coordinate system; B203, based on the peak or trough value points of the transcriptome data change trend line of the patient's gene and the peak or trough value points of the transcriptome data change trend line of the normal person's gene, processing to obtain the deviation value of the peak or trough value point, summing the deviation values to obtain the variance value, and using the variance value as the deviation dispersion value; If the gene expression abnormality judgment value is greater than or equal to the preset gene expression abnormality judgment threshold, it is determined that the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene have a large degree of dispersion, and the genetic disease suffered by the patient is caused by abnormal gene expression; If the abnormal gene expression judgment value is less than the preset abnormal gene expression judgment threshold, it is determined that the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene have a small degree of dispersion, and the genetic disease suffered by the patient is not caused by abnormal gene expression.
2. A method for analyzing characteristics of heterogeneous genetic data according to claim 1, Features: Step 4: Process the gene mutation determination value and the gene expression abnormality determination value to obtain a representative value of the genetic disease type and determine the type of genetic disease the patient suffers from.
3. A method for analyzing characteristics of heterogeneous genetic data according to claim 2, Features: In step 4, the processing of the gene mutation judgment value and the gene expression abnormality judgment value is as follows: C1, by the formula: The representative value W of the genetic disease type is obtained, D represents the gene mutation judgment value, P represents the gene expression abnormality judgment value, and α and β represent the preset proportional coefficients; C2, compare the genetic disease type determination value W with the preset genetic disease type determination threshold to obtain the genetic disease type.
4. A heterogeneous genetic data feature analysis system, the system being used to execute the method according to any one of claims 1 to 3 above, Features: include: Data acquisition module, data processing module and data analysis module; The data acquisition module is used to obtain data of patients with genetic diseases, and the genetic data includes the total number of patient genes detected, the number of gene mutations, the frequency of gene mutations and the transcriptome data of the patient's genes; The data processing module is used to process the number of gene mutations, the frequency of gene mutations and the transcriptome data of the patient's genes respectively to obtain the gene mutation judgment value and the gene expression abnormality judgment value; If the gene mutation determination value is greater than or equal to the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is caused by gene mutation; If the gene mutation determination value is less than the preset gene mutation determination threshold, it is determined that the genetic disease suffered by the patient is not caused by gene mutation; If the gene expression abnormality judgment value is greater than or equal to the preset gene expression abnormality judgment threshold, it is determined that the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene have a large degree of dispersion, and the genetic disease suffered by the patient is caused by abnormal gene expression; If the gene expression abnormality judgment value is less than the preset gene expression abnormality judgment threshold, it is determined that the divergence between the transcriptome data change trend line of the patient's gene and the transcriptome data change trend line of the normal person's gene is small, and the genetic disease suffered by the patient is not caused by abnormal gene expression; The data analysis module is used to analyze and determine the gene mutation judgment value and the gene expression abnormality judgment value to obtain the cause and type of the patient's genetic disease.
